Published in Cell on August 10, 2007
Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell (2010) 5.08
Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A (2008) 4.77
Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell (2012) 4.67
A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility. Genome Res (2008) 4.33
Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell (2010) 4.16
A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell (2009) 3.28
Endocrine regulation of male fertility by the skeleton. Cell (2011) 3.20
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. Nat Med (2013) 2.93
Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab (2008) 2.84
Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat (2009) 2.81
Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant (2010) 2.70
FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. J Clin Invest (2009) 2.46
Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int (2010) 2.40
Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism. J Clin Invest (2012) 2.38
Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study. Osteoporos Int (2011) 2.32
Inactivation of a novel FGF23 regulator, FAM20C, leads to hypophosphatemic rickets in mice. PLoS Genet (2012) 2.19
The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity. J Cell Biol (2008) 2.14
The contribution of bone to whole-organism physiology. Nature (2012) 2.03
Maternal and offspring pools of osteocalcin influence brain development and functions. Cell (2013) 2.00
Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab Syndr Relat Disord (2008) 1.95
Mechanical signals as anabolic agents in bone. Nat Rev Rheumatol (2010) 1.95
The transcriptional response of the islet to pregnancy in mice. Mol Endocrinol (2009) 1.89
Genetic evidence points to an osteocalcin-independent influence of osteoblasts on energy metabolism. J Bone Miner Res (2011) 1.89
Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone. J Bone Miner Res (2009) 1.85
Expansion of beta-cell mass in response to pregnancy. Trends Endocrinol Metab (2009) 1.81
Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis. J Clin Invest (2013) 1.81
Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone (2011) 1.75
The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. J Clin Invest (2009) 1.73
Bone, sweet bone--osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol (2012) 1.73
Minireview: Meeting the demand for insulin: molecular mechanisms of adaptive postnatal beta-cell mass expansion. Mol Endocrinol (2009) 1.72
PPARγ: a circadian transcription factor in adipogenesis and osteogenesis. Nat Rev Endocrinol (2010) 1.72
Osteocalcin promotes β-cell proliferation during development and adulthood through Gprc6a. Diabetes (2013) 1.68
Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo. PLoS One (2009) 1.67
PPARβ/δ governs Wnt signaling and bone turnover. Nat Med (2013) 1.66
Adolescent obesity, bone mass, and cardiometabolic risk factors. J Pediatr (2011) 1.66
Arterial calcification and bone physiology: role of the bone-vascular axis. Nat Rev Endocrinol (2012) 1.66
A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms. Mol Cell Endocrinol (2009) 1.64
GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome. PLoS One (2008) 1.63
Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol (2008) 1.62
ASXL2 Regulates Glucose, Lipid, and Skeletal Homeostasis. Cell Rep (2015) 1.54
Gamma-carboxylation of osteocalcin and insulin resistance in older men and women. Am J Clin Nutr (2009) 1.53
Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism. Genome Res (2011) 1.50
Association between vitamin K intake from fermented soybeans, natto, and bone mineral density in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) study. Osteoporos Int (2011) 1.50
Deletion of connexin43 in osteoblasts/osteocytes leads to impaired muscle formation in mice. J Bone Miner Res (2015) 1.50
Undercarboxylated osteocalcin is positively associated with free testosterone in male patients with type 2 diabetes mellitus. Osteoporos Int (2012) 1.50
Emerging therapeutic opportunities for skeletal restoration. Nat Rev Drug Discov (2011) 1.48
Importance of oestrogen receptors to preserve functional β-cell mass in diabetes. Nat Rev Endocrinol (2012) 1.47
Influence of pre- and peri-natal nutrition on skeletal acquisition and maintenance. Bone (2011) 1.45
New insights into osteoporosis: the bone-fat connection. J Intern Med (2012) 1.43
Impact of common variation in bone-related genes on type 2 diabetes and related traits. Diabetes (2012) 1.42
Bone regeneration and stem cells. J Cell Mol Med (2011) 1.41
Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol (2010) 1.40
Effect of vitamin K supplementation on insulin resistance in older men and women. Diabetes Care (2008) 1.40
GPRC6A mediates the non-genomic effects of steroids. J Biol Chem (2010) 1.38
Regulation of bone remodeling by the central and peripheral nervous system. Arch Biochem Biophys (2008) 1.36
Fat targets for skeletal health. Nat Rev Rheumatol (2009) 1.36
Osteoporosis, fractures, and diabetes. Int J Endocrinol (2014) 1.34
The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the "Fountain of Youth" to mediate healthful aging. J Steroid Biochem Mol Biol (2010) 1.34
The role of osteocalcin in human glucose metabolism: marker or mediator? Nat Rev Endocrinol (2012) 1.31
An ELISA-based method to quantify osteocalcin carboxylation in mice. Biochem Biophys Res Commun (2010) 1.29
Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator. Endocrinology (2009) 1.27
Strain-specific effects of rosiglitazone on bone mass, body composition, and serum insulin-like growth factor-I. Endocrinology (2008) 1.26
A role for myokines in muscle-bone interactions. Exerc Sport Sci Rev (2011) 1.26
Altered metabolism and lipodystrophy in the early B-cell factor 1-deficient mouse. Endocrinology (2010) 1.24
Marrow fat metabolism is linked to the systemic energy metabolism. Bone (2011) 1.23
Vitamin K-dependent carboxylation of osteocalcin: friend or foe? Adv Nutr (2012) 1.22
Bone tissue engineering with human stem cells. Stem Cell Res Ther (2010) 1.21
Biominerals--hierarchical nanocomposites: the example of bone. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 1.20
Novel insights into the relationship between diabetes and osteoporosis. Diabetes Metab Res Rev (2010) 1.19
Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1. Cell Metab (2013) 1.19
Protein meta-functional signatures from combining sequence, structure, evolution, and amino acid property information. PLoS Comput Biol (2008) 1.19
Bone and glucose metabolism: a two-way street. Arch Biochem Biophys (2010) 1.18
Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level. Osteoporos Int (2011) 1.18
Lower bone mass in prepubertal overweight children with prediabetes. J Bone Miner Res (2010) 1.17
Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation. J Clin Invest (2014) 1.13
aP2-Cre-mediated inactivation of acetyl-CoA carboxylase 1 causes growth retardation and reduced lipid accumulation in adipose tissues. Proc Natl Acad Sci U S A (2009) 1.13
The skeleton as an endocrine organ. Nat Rev Rheumatol (2012) 1.13
The role of androgens and estrogens on healthy aging and longevity. J Gerontol A Biol Sci Med Sci (2012) 1.13
FoxO1, the transcriptional chief of staff of energy metabolism. Bone (2011) 1.12
Ectopic and serum lipid levels are positively associated with bone marrow fat in obesity. Radiology (2013) 1.12
Signaling networks that control the lineage commitment and differentiation of bone cells. Crit Rev Eukaryot Gene Expr (2009) 1.11
AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass. Bone (2010) 1.11
Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation. Cell (2015) 1.09
Osteoblast-specific transcription factor Osterix (Osx) is an upstream regulator of Satb2 during bone formation. J Biol Chem (2011) 1.09
Phylloquinone intake, insulin sensitivity, and glycemic status in men and women. Am J Clin Nutr (2008) 1.08
Circulating osteogenic precursor cells in type 2 diabetes mellitus. J Clin Endocrinol Metab (2012) 1.08
Lower uncarboxylated osteocalcin concentrations in children with prediabetes is associated with beta-cell function. J Clin Endocrinol Metab (2011) 1.06
Trait-specific tracking and determinants of body composition: a 7-year follow-up study of pubertal growth in girls. BMC Med (2009) 1.06
Carboxylation of osteocalcin affects its association with metabolic parameters in healthy children. Diabetes Care (2009) 1.06
Repression of Runx2 by androgen receptor (AR) in osteoblasts and prostate cancer cells: AR binds Runx2 and abrogates its recruitment to DNA. Mol Endocrinol (2009) 1.06
Irisin enhances osteoblast differentiation in vitro. Int J Endocrinol (2014) 1.06
The many facets of PPARgamma: novel insights for the skeleton. Am J Physiol Endocrinol Metab (2010) 1.04
Poor glycemic control is associated with low BMD detected in premenopausal women with type 1 diabetes. Osteoporos Int (2008) 1.04
Role of subchondral bone during early-stage experimental TMJ osteoarthritis. J Dent Res (2011) 1.04
Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). J Clin Endocrinol Metab (2011) 1.03
Multiligand specificity and wide tissue expression of GPRC6A reveals new endocrine networks. Endocrinology (2012) 1.03
Gut-derived serotonin is a multifunctional determinant to fasting adaptation. Cell Metab (2012) 1.02
Endocrine actions of osteocalcin. Int J Endocrinol (2013) 1.02
Increased numbers of nonattached osteoclasts after long-term zoledronic acid therapy in mice. Endocrinology (2011) 1.01
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med (2001) 16.51
The hormone resistin links obesity to diabetes. Nature (2001) 15.49
Leptin and the regulation of body weight in mammals. Nature (1998) 14.84
Obesity and the regulation of energy balance. Cell (2001) 9.48
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature (2006) 9.36
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med (2002) 8.95
Adiponectin and adiponectin receptors. Endocr Rev (2005) 8.46
Genetic regulation of osteoclast development and function. Nat Rev Genet (2003) 7.94
Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell (2000) 7.87
The molecular basis of blood coagulation. Cell (1988) 5.29
Control of osteoblast function and regulation of bone mass. Nature (2003) 5.06
Increased bone formation in osteocalcin-deficient mice. Nature (1996) 4.91
Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes (2004) 4.37
Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast. Dev Dyn (2002) 4.01
The osteoblast: a sophisticated fibroblast under central surveillance. Science (2000) 3.93
Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev (1989) 3.87
Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. Mol Cell Biol (2005) 3.50
Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab (2006) 2.93
Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J Cell Biol (2004) 2.90
Emilin1 links TGF-beta maturation to blood pressure homeostasis. Cell (2006) 2.84
Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. J Clin Invest (2002) 2.65
Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci U S A (2006) 2.59
ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae. Cell Metab (2006) 2.55
Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest (1984) 2.52
The vitamin K-dependent carboxylase. Annu Rev Nutr (2005) 1.72
Gla-containing proteins of bone. Connect Tissue Res (1989) 1.56
A model to explore the interaction between muscle insulin resistance and beta-cell dysfunction in the development of type 2 diabetes. Diabetes (2000) 1.55
Overexpression of human adiponectin in transgenic mice results in suppression of fat accumulation and prevention of premature death by high-calorie diet. Am J Physiol Endocrinol Metab (2007) 1.48
THE BRAIN LESION OF GOLDTHIOGLUCOSE OBESITY. J Exp Med (1965) 1.46
Bone turnover and insulin-like growth factor I levels increase after improved glycemic control in noninsulin-dependent diabetes mellitus. Calcif Tissue Int (1998) 1.43
Knock-in of nuclear localised beta-galactosidase reveals that the tyrosine phosphatase Ptprv is specifically expressed in cells of the bone collar. Dev Dyn (2004) 1.30
Cloning of hOST-PTP: the only example of a protein-tyrosine-phosphatase the function of which has been lost between rodent and human. Biochem Biophys Res Commun (2004) 1.26
Identification of a hormonally regulated protein tyrosine phosphatase associated with bone and testicular differentiation. J Biol Chem (1994) 1.17
p53 mutant mice that display early ageing-associated phenotypes. Nature (2002) 10.05
Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem (2002) 9.76
Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell (2005) 7.64
Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2007) 6.76
Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature (2005) 6.43
Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol (2002) 6.20
Leptin regulates bone formation via the sympathetic nervous system. Cell (2002) 5.95
Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell (2008) 5.93
Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell (2004) 5.80
Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes (2008) 5.62
A twist code determines the onset of osteoblast differentiation. Dev Cell (2004) 5.40
A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science (2008) 5.28
ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell (2004) 5.27
Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell (2010) 5.08
A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J (2012) 5.03
Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A (2008) 4.77
Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes (2004) 4.37
SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell (2006) 4.01
The molecular clock mediates leptin-regulated bone formation. Cell (2005) 3.88
WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature (2005) 3.44
Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev (2005) 3.38
A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell (2009) 3.28
Endocrine regulation of male fertility by the skeleton. Cell (2011) 3.20
JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science (2012) 3.12
Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J Cell Biol (2004) 2.90
Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet (2003) 2.74
Enzyme replacement therapy for murine hypophosphatasia. J Bone Miner Res (2008) 2.64
Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci U S A (2006) 2.59
ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae. Cell Metab (2006) 2.55
FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. J Clin Invest (2009) 2.46
Txnip balances metabolic and growth signaling via PTEN disulfide reduction. Proc Natl Acad Sci U S A (2008) 2.41
Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. Diabetes (2005) 2.33
Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nat Med (2010) 2.32
Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism. Diabetes (2010) 2.30
Prevention of steatosis by hepatic JNK1. Cell Metab (2009) 2.20
Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis Rheum (2006) 2.19
PTHrP and Indian hedgehog control differentiation of growth plate chondrocytes at multiple steps. Development (2002) 2.19
Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human. Nat Med (2003) 2.17
miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2. J Cell Biol (2012) 2.15
The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity. J Cell Biol (2008) 2.14
Enamel defects and ameloblast-specific expression in Enam knock-out/lacz knock-in mice. J Biol Chem (2008) 2.05
A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains. Genome Biol (2013) 2.04
Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity. J Biol Chem (2007) 2.03
The contribution of bone to whole-organism physiology. Nature (2012) 2.03
Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle. Diabetes (2009) 2.00
Rescue of odontogenesis in Dmp1-deficient mice by targeted re-expression of DMP1 reveals roles for DMP1 in early odontogenesis and dentin apposition in vivo. Dev Biol (2006) 2.00
Maternal and offspring pools of osteocalcin influence brain development and functions. Cell (2013) 2.00
Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Horm IGF Res (2004) 1.96
Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Dev Cell (2006) 1.95
Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression. J Biol Chem (2005) 1.91
Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma. J Clin Invest (2004) 1.91
Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance. J Clin Invest (2007) 1.91
Genetic evidence points to an osteocalcin-independent influence of osteoblasts on energy metabolism. J Bone Miner Res (2011) 1.89
Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol (2002) 1.88
Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress. Diabetes (2008) 1.88
p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. J Cell Biol (2005) 1.86
An analysis of skeletal development in osteoblast-specific and chondrocyte-specific runt-related transcription factor-2 (Runx2) knockout mice. J Bone Miner Res (2013) 1.85
Efficacy of serotonin inhibition in mouse models of bone loss. J Bone Miner Res (2011) 1.84
Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis. J Clin Invest (2013) 1.81
Antidiabetic actions of estrogen: insight from human and genetic mouse models. Curr Atheroscler Rep (2004) 1.80
Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity. Cell Metab (2006) 1.76
Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone (2011) 1.75
Essential role of STAT3 in body weight and glucose homeostasis. Mol Cell Biol (2004) 1.74
Role of Rho-kinase in regulation of insulin action and glucose homeostasis. Cell Metab (2005) 1.73
The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. J Clin Invest (2009) 1.73